NewEdge Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-21,350
| Closed | -$616K | – | 3952 |
|
|
2024
Q3 | $616K | Buy |
+21,350
| New | +$616K | ﹤0.01% | 1353 |
|
|
2023
Q4 | – | Sell |
-7,274
| Closed | -$186K | – | 3797 |
|
|
2023
Q3 | $186K | Buy |
7,274
+532
| +8% | +$13.6K | ﹤0.01% | 1654 |
|
|
2023
Q2 | $177K | Sell |
6,742
-907
| -12% | -$23.8K | ﹤0.01% | 1678 |
|
|
2023
Q1 | $200K | Buy |
7,649
+1,384
| +22% | +$36.1K | ﹤0.01% | 1545 |
|
|
2022
Q4 | $172 | Buy |
+6,265
| New | +$172 | ﹤0.01% | 3316 |
|